ES8504200A1 - Procedimiento para la preparacion de derivados de benzodioxino pirrol. - Google Patents

Procedimiento para la preparacion de derivados de benzodioxino pirrol.

Info

Publication number
ES8504200A1
ES8504200A1 ES526738A ES526738A ES8504200A1 ES 8504200 A1 ES8504200 A1 ES 8504200A1 ES 526738 A ES526738 A ES 526738A ES 526738 A ES526738 A ES 526738A ES 8504200 A1 ES8504200 A1 ES 8504200A1
Authority
ES
Spain
Prior art keywords
compounds
cycloalkyl
image
treatment
benzodioxinopyrrole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526738A
Other languages
English (en)
Other versions
ES526738A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES526738A0 publication Critical patent/ES526738A0/es
Publication of ES8504200A1 publication Critical patent/ES8504200A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE BENZODIOXINO PIRROL, DE FORMULA GENERAL (I), EN LA QUE R ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO C1-16, Y SUS SALES FISIOLOGICAMENTE ACEPTABLES.CONSISTE EN AMINAR UN COMPUESTO DE FORMULA ESTRUCTURA (II), EN LA QUE X ES UN GRUPO SALIENTE, CON UN COMPUESTO DE FORMULA RNH2, EN PRESENCIA DE AGUA CUANDO R ES HIDROGENO.DE APLICACION EN EL TRATAMIENTO Y PREVENCION DE LA JAQUECA, TROMBOSIS, DIABETES, OBESIDAD, HIPERTENSION Y ESTREN/IMIENTO.
ES526738A 1982-10-25 1983-10-25 Procedimiento para la preparacion de derivados de benzodioxino pirrol. Expired ES8504200A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8230379 1982-10-25

Publications (2)

Publication Number Publication Date
ES526738A0 ES526738A0 (es) 1985-04-16
ES8504200A1 true ES8504200A1 (es) 1985-04-16

Family

ID=10533819

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526738A Expired ES8504200A1 (es) 1982-10-25 1983-10-25 Procedimiento para la preparacion de derivados de benzodioxino pirrol.

Country Status (18)

Country Link
US (1) US4496579A (es)
JP (1) JPS5998086A (es)
KR (1) KR840006486A (es)
AU (1) AU2055283A (es)
BE (1) BE898072A (es)
CH (1) CH661046A5 (es)
DE (1) DE3338753A1 (es)
ES (1) ES8504200A1 (es)
FI (1) FI833887A7 (es)
FR (1) FR2534921B1 (es)
GB (1) GB2129795B (es)
GR (1) GR79405B (es)
IL (1) IL70034A0 (es)
IT (1) IT1212893B (es)
LU (1) LU85059A1 (es)
NL (1) NL8303673A (es)
SE (1) SE8305866L (es)
ZA (1) ZA837921B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2201414B (en) * 1984-04-24 1988-12-29 Glaxo Group Ltd Heterocyclic amino compounds
US4769367A (en) * 1984-04-24 1988-09-06 Glaxo Group Limited Heterocyclic amino compounds
GB8410459D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Chemical compounds
GB8526210D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical compounds
GB8526209D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical process
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8828032D0 (en) * 1988-12-01 1989-01-05 Glaxo Group Ltd Medicaments
DE10107243A1 (de) * 2001-02-16 2002-08-22 Bayer Ag Benzodioxinopyrrole, deren Herstellung und Verwendung
US20070078569A1 (en) * 2005-09-30 2007-04-05 Jeffrey Schox Vehicle interface to communicate a safety alert mode command
US20090076686A1 (en) * 2005-09-30 2009-03-19 Jeffrey Schox Vehicle interface to communicate a safety alert mode command
US20070074922A1 (en) * 2005-09-30 2007-04-05 Coombs Joshua D Vehicle interface based on a shift of the torso of a user
US20070074921A1 (en) * 2005-09-30 2007-04-05 Coombs Joshua D Vehicle interface based on a shift of the appendages of a user
US8099200B2 (en) 2005-09-30 2012-01-17 Coombs Joshua D Vehicle interface based on the weight distribution of a user

Also Published As

Publication number Publication date
IL70034A0 (en) 1984-01-31
FR2534921B1 (fr) 1987-01-16
NL8303673A (nl) 1984-05-16
ES526738A0 (es) 1985-04-16
IT8349214A0 (it) 1983-10-25
KR840006486A (ko) 1984-11-30
US4496579A (en) 1985-01-29
IT1212893B (it) 1989-11-30
CH661046A5 (fr) 1987-06-30
DE3338753A1 (de) 1984-04-26
FI833887A7 (fi) 1984-04-26
GB2129795B (en) 1986-02-12
GB8328468D0 (en) 1983-11-23
ZA837921B (en) 1985-04-24
AU2055283A (en) 1984-05-03
FR2534921A1 (fr) 1984-04-27
JPS5998086A (ja) 1984-06-06
GB2129795A (en) 1984-05-23
SE8305866D0 (sv) 1983-10-25
FI833887A0 (fi) 1983-10-25
LU85059A1 (fr) 1985-06-19
BE898072A (fr) 1984-04-25
SE8305866L (sv) 1984-04-26
GR79405B (es) 1984-10-22

Similar Documents

Publication Publication Date Title
SE8305866L (sv) Heterocykliska foreningar och forfaranden for deras framstellning
NZ335363A (en) Naphthyridine derivatives
IL82149A0 (en) 4h-1-benzopyran-4-one derivatives,process for their preparation and pharmaceutical compositions containing them
ES8702393A1 (es) Un procedimiento para preparar un derivado de 1-bencil-4- benzhidril-piperazina
SE0200730D0 (sv) Kristallin bas av citalopram
DK623586D0 (da) Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
HK85690A (en) Indole derivatives
BG100154A (en) Carbazole derivatibes having inhibiting effect to 17,20-lyase
ES8301967A1 (es) Procedimiento de preparar compuestos carbostirilicos.
ATE148990T1 (de) Ebastin oder ebastin-analoga enthaltende arzneimittel
ES8303291A1 (es) Un procedimiento para la preparacion de nuevos derivados de ariletanolamina.
GB2103203A (en) 1,4-dihydropyridines, their preparation and pharmaceutical compositions containing them
IE832581L (en) Piperidinedione derivatives, possessing anti-arrythmic¹activity, for protecting the myocardium, process for their¹preparation and pharmaceutical compositions containing said¹derivatives
US3689504A (en) N-substituted -alpha-methyl-3,4-(methylenedioxy) phenethylamines
LTIP1960A (en) Positive inotropic and lusitropic pyrroloquinolinone derivatives, method for preparing thereof, pharmaceutical composition and method for preparing the same
DK156064C (da) Analogifremgangsmaade til fremstilling af 2,4-(1h,3h)-quinazolindionderivater eller farmaceutisk acceptable syreadditionssalte deraf
IL151488A0 (en) Method for the preparation of citalopram
PT99911A (pt) Processo para a preparacao de 11beta-aril-4-estrenos modificados em posicao 6,7 e de composicoes farmaceuticas que os contem
DK1121109T3 (da) Tofaset sammensætning med tramadol
ATE8786T1 (de) Indolobenzoxazinderivate, ihre salze, verfahren zur herstellung, ihre verwendung als arzneimittel und sie enthaltende zusammensetzungen.
ES8305329A1 (es) Procedimiento para la preparacion de 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas.
PT80787A (en) Process for preparing piperidine (or pyrrolidine)-butanamides and compounds relating to them
ZA881383B (en) 2-(2,3-dihydro-2-oxo-3-benzofuranyl)acetic acid derivatives,processes for preparing them and the pharmaceutical compositions which contain them
JPS57102829A (en) 1-halogeno-6-methyl-5-hepten-2-ol, its derivative, and their preparation
DE69105108D1 (de) Substituierte N-[Phenyl-(thioxomethyl)]-morpholinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Zusammensetzung und ihre Verwendung.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991108